Myriad Genetics Inc (NASDAQ:MYGN)

35.76
Delayed Data
As of Mar 27
 +0.21 / +0.59%
Today’s Change
31.56
Today|||52-Week Range
42.50
+4.99%
Year-to-Date

Today’s Trading

Previous close35.55
Today’s open35.43
Day’s range35.43 - 36.56
Volume590,782
Average volume (3 months)893,269
Market cap$2.5B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-37.26%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+26.92%
P/E ratio24.7
Price/Sales3.31
Price/Book3.63

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+1.23+1.70%
WXWuxi Pharmatech Caym...+0.36+0.97%
HZNPHorizon Pharma PLC+0.69+3.27%
LCILannett Company Inc-0.32-0.49%
Data as of 4:03pm ET, 03/27/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)$0.39
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account